Acyclovir and Xyzal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Acyclovir (acyclovir) and Xyzal (levocetirizine dihydrochloride). Common drug interactions include weight fluctuation among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Acyclovir and Xyzal. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.

What is Acyclovir?

Acyclovir has active ingredients of acyclovir. It is often used in herpes simplex. eHealthMe is studying from 54,961 Acyclovir users. Check the latest studies of Acyclovir.

What is Xyzal?

Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.



On Aug, 11, 2026

99 people who take Acyclovir and Xyzal together, and have interactions are studied.

Acyclovir and Xyzal drug interactions.

What are the common drug interactions of Acyclovir and Xyzal, by gender? *:

female:

  1. Weight fluctuation
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Back disorder
  4. Back pain
  5. Blood pressure orthostatic
  6. Bowel movement irregularity
  7. Breath holding
  8. Cardiac disorder
  9. Chest discomfort
  10. Chest pain

male:

  1. Pneumonia
  2. Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
  3. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  4. Drug intolerance (drug sensitivity)
  5. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  6. Dyspnoea (difficult or laboured respiration)
  7. Encephalitis (inflammation of the brain)
  8. Fatigue (feeling of tiredness)
  9. Gamma-glutamyltransferase increased
  10. Listeriosis (a food borne illness caused by listeria monocytogenes, bacteria found in soil and water)

What are the common drug interactions of Acyclovir and Xyzal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Diarrhoea
  2. Flatulence (flatus expelled through the anus)
  3. Abdominal distension
  4. Fungal infection
  5. Moaning (a low, sustained, mournful cry)
  6. Urinary tract infection
  7. Constipation
  8. Aerophagia (excessive air swallowing)
  9. Crying
  10. Drug ineffective

30-39:

  1. Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
  2. Anxiety
  3. Crying
  4. Depression
  5. Dizziness
  6. Drug hypersensitivity
  7. Fatigue (feeling of tiredness)
  8. Hallucination (an experience involving the perception of something not present)
  9. Headache (pain in head)
  10. Insomnia (sleeplessness)

40-49:

  1. Ankle fracture
  2. Craniocerebral injury (injury to cranium and brain)
  3. Ligament sprain (ligament stretched)
  4. Multiple fractures
  5. Osteopenia (a condition where bone mineral density is lower than normal)
  6. Osteoporosis (bones weak and more likely to break)
  7. Panic attack
  8. Parathyroid disorder
  9. Sinusitis (inflammation of sinus)
  10. Upper respiratory tract infection

50-59:

  1. Dyspnoea (difficult or laboured respiration)
  2. Emotional distress
  3. Pain
  4. Productive cough
  5. Cholangitis (infection of the bile duct)
  6. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  7. Arthralgia (joint pain)
  8. Aspartate aminotransferase increased
  9. Back pain
  10. Bone density decreased

60+:

  1. Pneumonia
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Arthralgia (joint pain)
  5. Aspartate aminotransferase increased
  6. Back pain
  7. Blood creatinine increased
  8. Blood pressure increased
  9. C-reactive protein increased
  10. Cardiac failure chronic

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 24 people, 24.24%
  2. Immunodeficiency Common Variable: 15 people, 15.15%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 8.08%
  4. High Blood Pressure: 8 people, 8.08%
  5. Type 2 Diabetes: 6 people, 6.06%
  6. Hypersensitivity: 6 people, 6.06%
  7. Constipation: 5 people, 5.05%

* Approximation only. Some reports may have incomplete information.

Do you take Acyclovir and Xyzal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Acyclovir and Xyzal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Acyclovir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xyzal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Acyclovir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xyzal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on acyclovir and levocetirizine dihydrochloride (the active ingredients of Acyclovir and Xyzal, respectively), and Acyclovir and Xyzal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: